HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison

被引：0
|
作者：
T. Koopman
M. M. Smits
M. Louwen
M. Hage
H. Boot
A. L. T. Imholz
机构：
[1] Deventer Hospital,Department of Medical Oncology
[2] Deventer Hospital,Department of Pathology
[3] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Gastroenterology and Hepatology
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Gastric cancer; Esophageal cancer; Gastroesophageal cancer; Human epidermal growth factor 2 (HER2); Primary tumor location;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1343 / 1351
页数：8
相关论文
共 50 条
  • [1] HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison
    Koopman, T.
    Smits, M. M.
    Louwen, M.
    Hage, M.
    Boot, H.
    Imholz, A. L. T.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (08) : 1343 - 1351
  • [2] Pathologic Diagnostics of HER2 Positivity in Gastroesophageal Adenocarcinoma
    Koopman, Timco
    Louwen, Maarten
    Hage, Mariska
    Smits, Maria M.
    Imholz, Alex L. T.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 257 - 264
  • [3] Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma
    Kaur, Antarpreet
    Dasanu, Constantin A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2493 - 2503
  • [4] Overexpression of HER2/Neu in gastric adenocarcinoma and its correlation with clinicopathological parameters
    Kaur, Roop
    Mardi, Kavita
    Negi, Lalita
    Dheer, Ankita
    CLINICAL CANCER INVESTIGATION JOURNAL, 2021, 10 (04): : 209 - 213
  • [5] HER2 Directed Therapy for Gastric/Esophageal Cancers
    Elizabeth Won
    Yelena J. Janjigian
    David H. Ilson
    Current Treatment Options in Oncology, 2014, 15 : 395 - 404
  • [6] HER2 Directed Therapy for Gastric/Esophageal Cancers
    Won, Elizabeth
    Janjigian, Yelena J.
    Ilson, David H.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (03) : 395 - 404
  • [7] HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
    Ling Shan
    Jianming Ying
    Ning Lu
    Diagnostic Pathology, 8
  • [8] HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
    Shan, Ling
    Ying, Jianming
    Lu, Ning
    DIAGNOSTIC PATHOLOGY, 2013, 8
  • [9] Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia
    Rajadurai P.
    Fatt H.K.
    Ching F.Y.
    Journal of Gastrointestinal Cancer, 2018, 49 (2) : 150 - 157
  • [10] HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
    Huang, Jun-Xing
    Zhao, Kun
    Lin, Mei
    Wang, Qi
    Xiao, Wei
    Lin, Mao-Song
    Yu, Hong
    Chen, Ping
    Qian, Rong-Yu
    ONCOLOGY LETTERS, 2013, 6 (01) : 13 - 18
12345